| Amylyx Pharmaceuticals Inc |
1.48 |
| First Tracks Biotherapeutics Inc |
1.47 |
| AbCellera Biologics Inc |
1.34 |
| Xencor Inc |
1.31 |
| Monopar Therapeutics Inc |
1.16 |
| AtaiBeckley Inc |
1.15 |
| MBX Biosciences Inc |
1.10 |
| uniQure NV |
1.10 |
| Replimune Group Inc |
1.08 |
| SELLAS Life Sciences Group Inc |
1.05 |
